Peptide-based Cardiovascular Therapeutics Market

Peptide-based Cardiovascular Therapeutics Market is segmented by Product (Natriuretic & Vasoactive Peptides, Antithrombotic Peptides, PCSK9-Targeting Peptides, Other Cardioprotective Peptides), Application (Dyslipidemia, Heart Failure, Coronary Artery Disease, Thrombotic Disorders), End Use (Hospitals, Specialty Cardiac Clinics, Research Institutes, Pharmaceutical & Biotech Companies), and Region, with forecasts covering the period from 2026 to 2036.